Barings Global Short Duration High Yield Fund Announces

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
46
Barings Global Short Duration High Yield Fund Announces March 2017 Monthly Distribution of $0.1534 per Share

CHARLOTTE, N.C., March 09, 2017 (GLOBE NEWSWIRE) -- Barings Global Short Duration High Yield Fund (the “Fund”) (NYSE: BGH ) announced its monthly dividend for March 2017 of $0.1534 per share, payable on April 3, 2017.  Based on the Fund’s February 28, 2017 share price of $20.09 per share, the distribution represents an annualized yield of 9.16% per share.  Based on current projections through the payable date, the Fund expects that this distribution will be comprised of net investment income.

Additionally, the Fund announced estimated monthly distributions of $0.1534 per share for April 2017 and May 2017.  The distribution schedule appears below:

Month           Ex-Date           Record Date           Payable Date           Amount 1
March           03/21/2017           03/23/2017           04/03/2017           $ 0.1534
April           04/18/2017           04/20/2017           05/01/2017           $ 0.1534
May           05/18/2017           05/20/2017           06/01/2017           $ 0.1534

Amounts represent estimates for April and May.

The Fund seeks to pay a distribution at a rate that reflects net investment income actually earned. A portion of each distribution may be treated as paid from sources other than net investment income, including but not limited to short-term capital gain, long-term capital gain or return of capital. The final determination of the source and tax characteristics of these distributions will depend upon the Fund’s investment experience during its fiscal year and will be made after the Fund’s year end. The Fund will send to investors a Form 1099-DIV for the calendar year that will define how to report these distributions for federal income tax purposes.

The Fund is a non-diversified, closed-end management investment company that is managed by Barings LLC.  The Fund invests primarily in short-duration, global high yield bonds with the objective of seeking as high a level of current income as Barings determines is consistent with capital preservation, with a secondary objective of capital appreciation.  The Fund expects to maintain a weighted average portfolio duration, including the effects of leverage, of 3 years or less.

Cautionary Notice: Certain statements contained in this press release may be "forward looking" statements.  Investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date in which they are made and which reflect management’s current estimates, projections, expectations or beliefs, and which are subject to risks and uncertainties that may cause actual results to differ materially.  These statements are subject to change at any time based upon economic, market or other conditions and may not be relied upon as investment advice or an indication of the fund's trading intent.  References to specific securities are not recommendations of such securities, and may not be representative of the fund's current or future investments.  We undertake no obligation to publicly update forward looking statements, whether as a result of new information, future events, or otherwise. 

Because the Fund is newly organized, its shares have a limited history of public trading. Investors should read the Fund’s prospectus and consider carefully the risks, investment objectives, charges and expenses associated with an investment in the Fund’s common shares. For a copy of the prospectus, please contact your securities representative.

About Barings Barings is a $271 billion* global asset management firm dedicated to meeting the evolving investment and capital needs of our clients. We build lasting partnerships that leverage our distinctive expertise across traditional and alternative asset classes to deliver innovative solutions and exceptional service. A member of the MassMutual Financial Group, Barings maintains a strong global presence with over 600 investment professionals and offices in 17 countries. Learn more, at www.barings.com .

Brian Whelan, Barings, (980) 417-7700, brian.whelan@barings.com

*As of December 31, 2016.

17/200

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Construction Leaders Unite to Combat Worker Suicide Crisis

Updated Category News Views 53

Construction Leaders Unite to Combat Worker Suicide Crisis In a significant move to address the alarming rate of suicide among construction workers, leading CEOs from prominent firms including Bechtel, Fluor, and Turner Construction Company have launched a new CEO Advisory Council. This initiative aims to drive awareness and develop effective solutions for mental health...

Continue Reading
Jack DiFranco Joins Woodward Park Partners Amid Growth Surge

Updated Category News Views 432

New Face, New Opportunities Talk about a shake-up! Woodward Park Partners just snagged Jack DiFranco, a heavyweight in the mergers and acquisitions arena. This isn’t just a name drop; we’re talking about 35 years of serious industry grind under his belt. DiFranco isn't just here to fill a seat; he’s got the chops to elevate this firm into a new realm of...

Continue Reading
BitMine's Ethereum Strategy Surges with $2 Billion in Holdings

Updated Category News Views 267

BitMine's Revolutionary Ethereum Holdings Strategy BitMine Immersion Technologies has achieved a remarkable milestone by surpassing $2 billion in Ethereum (ETH) holdings. This significant increase over the initial $250 million capital raise demonstrates the company's strong asset management and commitment to its treasury strategy. The journey began with a private...

Continue Reading
Fennec Pharmaceuticals Prepares for Q1 2025 Results Announcement

Updated Category News Views 139

Fennec Pharmaceuticals Set to Release Quarterly Financial Results RESEARCH TRIANGLE PARK, N.C. -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a dedicated specialty pharmaceutical company, has made an important announcement regarding its first quarter financial results for 2025. The company is on track to unveil these results before the U.S. financial markets...

Continue Reading
Stellantis Faces Lowest Italian Vehicle Production in Decades

Updated Category News Views 376

Stellantis and Its Production Challenges in Italy Stellantis (NYSE: STLA), the result of a major merger between iconic brands, is experiencing a notable decline in vehicle production within Italy. This setback is particularly concerning as it represents the lowest output levels this country has seen since 1956. Declining Production Figures Reported Recent data from union...

Continue Reading